You are viewing: South Korea Medical Plastics Market analysis
Part of: Medical Plastics Market (Global)

The South Korea Medical Plastics Market was valued at $1235.4 Million in 2026 and projected to reach to $1699.5 Million by 2031, representing a compound annual growth rate of 6.6%. South Korea's medical plastics market is experiencing robust growth driven by its advanced healthcare system and increasing prevalence of chronic diseases requiring innovative medical solutions.

South Korea Medical Plastics Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Medical Plastics Market Trends and Insights

  • This growth trajectory reflects South Korea's advanced healthcare infrastructure, rising demand for minimally invasive medical devices, and increasing adoption of single-use plastic components in clinical settings.
  • South Korea's strong manufacturing capabilities and regulatory compliance standards continue to drive market expansion across diagnostic, surgical, and pharmaceutical delivery applications. The 6.6% compound annual growth rate (CAGR) through 2031 underscores South Korea's strategic importance in the global medical plastics supply chain.
  • South Korea benefits from robust domestic healthcare spending, an aging population requiring advanced medical interventions, and significant investment in biotechnology and medical device innovation.
  • South Korea's position as a regional hub for medical device manufacturing further accelerates demand for high-performance, biocompatible plastic materials that meet stringent international quality standards..

Key Market Statistics

  • CAGR (2026-2031) 6.6% CAGR
  • Market Size, 2026 ~USD 1235.4 Million
  • Forecast, 2031 ~USD 1699.5 Million
  • Country South Korea

South Korea Medical Plastics Market Overview

Advanced Healthcare Infrastructure :

South Korea's sophisticated medical device ecosystem and high healthcare spending drive demand for premium medical plastics in diagnostic and surgical applications.

Minimally Invasive Device Adoption :

Growing preference for minimally invasive procedures in South Korean hospitals increases consumption of specialized plastic components for endoscopes, catheters, and surgical instruments.

Single-Use Component Expansion :

Heightened infection control awareness post-pandemic accelerates adoption of single-use plastic medical devices across South Korean healthcare facilities.

Strong Manufacturing Base :

South Korea's established medical device manufacturing sector and polymer processing capabilities support local production and innovation in medical plastics.

South Korea Medical Plastics Market Dynamics

  • The market's expansion from USD 1,235.4 million in 2026 to USD 1,699.5 million by 2031 reflects strong demand for high-performance plastic materials in diagnostic devices, drug delivery systems, and surgical applications. Key growth catalysts include rising geriatric population, increased healthcare expenditure, and regulatory support for medical device innovation.
  • South Korea's position as a global medical device hub, combined with technological advancements in biocompatible plastics and manufacturing processes, positions the country for sustained market expansion at a 6.6% CAGR through 2031..

Market Ecosystem

logo-mobile

MEDICAL PLASTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Lubrizol develops medical-grade thermoplastic polyurethanes (TPUs), specialty polymers, and engineered materials for catheters, wearable medical devices, drug delivery systems, wound care products, prosthetics, and other high-performance medical components. Outstanding flexibility | Biocompatibility | Abrasion resistance | Chemical resistance | Sterilization compatibility while enabling miniaturization, patient comfort, and long-term device durability in demanding healthcare applications
Celanese manufactures high-performance medical polymers including acetal (POM), thermoplastic elastomers (TPEs), engineered nylons, and specialty compounds used in surgical instruments, inhalers, insulin pens, diagnostic equipment, implant components, and reusable medical devices. Excellent mechanical strength | Dimensional stability | Wear resistance | Low friction | Sterilization compatibility, enabling lightweight, durable, and precision-engineered medical products with long service life
SABIC supplies medical-grade polycarbonate (PC), polypropylene (PP), polyethylene (PE), and specialty copolymers for medical disposables, diagnostic equipment, pharmaceutical packaging, respiratory devices, laboratory consumables, and healthcare electronics. High impact strength | Optical clarity | Chemical resistance | Gamma and EtO sterilization compatibility | Excellent processability | Comprehensive regulatory documentation, making them ideal for high-volume medical manufacturing
Covestro provides Makrolon® polycarbonate, thermoplastic polyurethane (TPU), and other specialty medical polymers for medical device housings, diagnostic equipment, infusion systems, surgical instruments, wearable healthcare devices, and pharmaceutical packaging. Exceptional toughness | Transparency | Design flexibility | Repeated sterilization capability | Biocompatibility while supporting lightweight, durable, and sustainable medical product development

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Resins And Polymers

Top Technologies
  • Polycarbonate
  • Acrylonitrile Butadiene Styrene (ABS)
  • Epoxy Resin
  • Light Commercial Vehicles (LCVs)
  • Polypropylene (PP)
Top Companies
  • Basf se
  • DOW CHEMICAL COMPANY
  • Solvay sa
  • Saudi arabia basic industries corporation (sabic)
  • DuPont de Nemours, Inc.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • South Korea's medical plastics market is valued at USD 1,235.4 million in 2026, expanding to USD 1,699.5 million by 2031 at a 6.6% CAGR.
      • South Korea's advanced healthcare infrastructure and aging demographic drive sustained demand for innovative medical plastic components.
      • South Korea's manufacturing excellence and regulatory compliance position it as a key regional supplier of medical-grade plastics.
      • South Korea's investment in biotechnology and minimally invasive device development accelerates adoption of specialized plastic materials through 2031.

      Medical Plastics Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment PP (Type)
      Forecast Period 2026-2031
      Growth Rate CAGR of 7% from 2026 to 2031
      Largest Segment OTHER MEDICAL PLASTICS (Type)
      Market Size Base Year (Billions) ~USD 34.77 (2026)
      Revenue Forecast (Billions) ~USD 48.77 (2031)
      Segments Covered Type, Application

      South Korea Medical Plastics Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Type

      • Engineering And High Performance Plastics
      • Other Medical Plastics
      • Pe
      • Pmma
      • Pp
      • Ps
      • Pvc
      • -Abs
      • -Others
      • -Pa
      • -Pc
      • -Peek
      • -Ppsu
      • -Psu

      By Application

      • Drug Delivery
      • Medical Disposables
      • Medical Instruments & Devices
      • Medical Packaging
      • Other Applications
      • Prosthetics & Implants

      Target Audience

      • Medical Device Manufacturers : Manufacturers need South Korea-specific market data to identify growth opportunities, assess local demand for plastic components, and develop region-tailored product strategies.
      • Plastic Material Suppliers : Suppliers require detailed insights into South Korean healthcare facility requirements, material specifications, and procurement patterns to optimize product portfolios and sales strategies.
      • Healthcare Investors & PE Firms : Investment professionals need comprehensive market analysis of South Korea's medical plastics sector to evaluate acquisition targets, growth potential, and return on investment opportunities.
      • Market Entry Consultants : Consultants advising companies on South Korea expansion require localized market intelligence, competitive dynamics, and regulatory landscape data for strategic planning.
      • Healthcare Procurement Officers : Hospital and clinic procurement teams need market insights to understand supplier capabilities, pricing trends, and material innovations available in South Korea's medical plastics market.

      Reasons to Buy this Report

      • Market Size & Growth Projections : Access precise valuation data for South Korea's medical plastics market with detailed CAGR analysis (6.6%) and forecasts through 2031 to support investment decisions.
      • Competitive Landscape Intelligence : Identify key manufacturers, suppliers, and market players operating in South Korea's medical plastics sector to benchmark competitive positioning and partnership opportunities.
      • Regulatory & Compliance Insights : Understand South Korea-specific medical device regulations, quality standards, and certification requirements affecting market entry and product development strategies.
      • Application-Specific Demand Analysis : Gain detailed insights into demand drivers across diagnostic devices, drug delivery, surgical instruments, and other medical applications unique to South Korea's healthcare market.
      • Strategic Market Entry Planning : Leverage South Korea-focused data to develop localized go-to-market strategies, identify distribution channels, and assess partnership potential with local healthcare providers.

      Frequently asked questions

      What is the current market size of medical plastics in South Korea?

      South Korea's medical plastics market is valued at USD 1,235.4 million in 2026 and is projected to reach USD 1,699.5 million by 2031.

      What is the expected growth rate for South Korea's medical plastics market?

      South Korea's medical plastics market is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2031.

      What factors are driving growth in South Korea's medical plastics sector?

      South Korea's growth is driven by advanced healthcare infrastructure, an aging population, rising demand for minimally invasive devices, and strong domestic medical device manufacturing capabilities.

      Which applications dominate South Korea's medical plastics market?

      South Korea's medical plastics market is primarily driven by diagnostic devices, surgical instruments, pharmaceutical delivery systems, and single-use clinical components.

      How does South Korea's market compare to the broader Asia Pacific region?

      South Korea represents a significant and mature segment within Asia Pacific, characterized by high regulatory standards, advanced manufacturing, and strong healthcare spending relative to regional peers.

      RESEARCH METHODOLOGY

      The study involved four major activities to estimate the current size of the global medical plastics market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of medical plastics through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

      Secondary Research

      The market for companies offering medical plastics was derived from secondary data available through paid and unpaid sources, by analyzing the product portfolios of the major companies in the ecosystem, and by rating the companies based on their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to for identifying and collecting  information for this study on the medical plastics market. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of door vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

      Primary Research

      In the primary research process, various primary sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the medical plastics market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at.

      Primary research was also conducted to identify the segmentation, industry trends, competitive landscape of medical plastics offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

      The following is the breakdown of primary respondents:

      Medical Plastics Market Size, and Share

      Notes: Other designations include sales, marketing, and product managers.
      Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The top-down and bottom-up approaches were used to estimate and validate the size of the global medical plastics market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

      Medical Plastics Market : Top-Down and Bottom-Up Approach

      Medical Plastics Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from the demand and supply sides.

      Market Definition

      Medical plastics refer to polymer materials that are designed specifically for use in medical and life science applications where certain performance parameters such as procedure compatibility, mechanical properties, sterilization, and compliance with regulations are of utmost importance. These materials are widely used to make medical devices such as medical disposables, medical instruments, implants, and drug delivery systems. Generally used plastics are classified as basic plastics, engineering plastics, high-performance plastics, and silicone plastics, and the appropriate plastic type is chosen on the basis of the functional performance required for a particular application. Medical plastics are manufactured with the use of sophisticated processes that include but are not limited to injection molding, extrusion, blow molding, thermoforming, compression molding, and additive manufacturing.

      Key Stakeholders

      • Medical plastics manufacturers
      • Medical-grade polymer and resin suppliers
      • Medical device manufacturers
      • Pharmaceutical and biotechnology companies
      • Healthcare providers (hospitals, clinics, and ambulatory surgical centers)
      • Regulatory bodies and industry associations
      • Research institutes and diagnostic laboratories

      Report Objectives

      • To describe and forecast the size of the global medical plastics market, by type and application, in terms of value and volume
      • To forecast the market size of segments and subsegments for five regions: North America, Europe, Asia Pacific, South America, and the Middle East & Africa, in terms of value
      • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
      • To strategically analyze micro-markets concerning individual growth trends, prospects, and their contribution to the market
      • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
      • To strategically profile key players and comprehensively analyze their market shares and core competencies
      • To analyze competitive developments such as product launches, acquisitions, expansions, partnerships, and agreements in the market
      • To analyze the impact of AI on the market

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations according to client-specific needs.
      The following customization options are available for the medical plastics market report:

      Product analysis

      • A product matrix that gives a detailed comparison of the product portfolio of each company

      Geographic analysis

      • A further breakdown of the medical plastics market for additional countries

      Company information

      • Detailed analysis and profiling of additional market players (up to five)

       

      Get the Full Medical Plastics Market Report

      Full forecast, segment splits, and company analysis for all Medical Plastics Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status